Yet, the results of our pooled analysis indicated that HER2 expression is also strongly related to intestinal-type tumors and well-differentiated gastric cancers, which usually have a better prognosis than diffuse-type tumors or poorly differentiated cancers. The gene discussed is ERBB2; the disease is cancer.